Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

Aleena Banerji(Massachusetts General Hospital), Burt Adelman(Unknown), Mustafa M. Shennak(Massachusetts General Hospital), Ryan Faucette(Massachusetts General Hospital), Harvey Kushner(Massachusetts General Hospital), Jon Kenniston(Massachusetts General Hospital), Carolyn Soo(Massachusetts General Hospital), Marc A. Riedl(La Jolla Institute for Immunology), Mark Davis‐Lorton(Winthrop-University Hospital), Ryan Iarrobino(Massachusetts General Hospital), Ahmad Al‐Ghazawi(Massachusetts General Hospital), Paula J. Busse(Massachusetts General Hospital), James Still(Massachusetts General Hospital), Timothy Craig(Vinmec International Hospital), H. James Wedner(Washington University in St. Louis), James Baker(Technology and Management Services (Switzerland)), Marco Cicardi, Yung Chyung(Massachusetts General Hospital), Robert Mensah(Massachusetts General Hospital), Daniel J. Sexton(Takeda (United States)), Jonathan A. Bernstein(Bernstein Clinical Research Center), Joseph C. Biedenkapp(Massachusetts General Hospital), William R. Lumry(The University of Texas Southwestern Medical Center), Chris Stevens(Massachusetts General Hospital), H. Henry Li(Institute for Asthma and Allergy), Joshua Jacobs(California Allergy and Asthma Medical Group), Christopher TenHoor(Massachusetts General Hospital), Richard F. Lockey(University of South Florida)
New England Journal of Medicine
February 17, 2017
Cited by 171


Related Papers